Neuren Pharmaceuticals LimitedASX: NEU

Orphan drug designation from FDA for NNZ-2566 in Fragile X

Feb 10, 2016 at 8:19 PM EST · Issued by Neuren Pharmaceuticals Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

6ix hasn’t read this filing yet.

Follow Neuren Pharmaceuticals into a list and get an email when it puts out news.